About Anthony DiTonno
Anthony DiTonno is CEO and director at Dignify Therapeutics.
Anthony DiTonno reports to the SEC as a director or officer of 2 public companies: Tenax Therapeutics (TENX) and NeurogesX (NGSX).
Anthony DiTonno first appears on SEC filings in 2007.
Experience
This experience comes from Anthony DiTonno's profile and from SEC filings. For roles taken from filings, the years are when the filings name Anthony DiTonno in the role, so the role may have started earlier or lasted longer.
Dignify Therapeutics, LLC Current
CEO and director
Executive Chairman (2022 – Present)
2022 – Present · Research Triangle Park, NC
Develops bowel and bladder drugs for older adults and people with neurological conditions.
WJ
WJP Current
Retired
2018 – Present
TI
Tenax Therapeutics, Inc.
Chief Executive Officer (2018 – 2021)
Director
2012 – 2021 · Public company (TENX)
AS
Avantis Medical Systems
President and Chief Executive Officer
2013 – 2018
AC
AAD Consulting
Consultant
2011 – 2012
NI
NeurogesX Inc
President and CEO, director
2003 – 2011 · Public company (NGSX)
ET
Enteric Medical Technology
EVP
2000 – 2002
OP
Oclassen Pharmaceuticals
Vice President and General Manager (1996 – 1997)
Vice President Sales and Marketing (1989 – 1996)
1989 – 1997
RR
Rhone Poulenc Rorer
Director Business Development
1987 – 1989
RP
Rorer Pharmaceuticals
Director Business Development
1976 – 1989
Key Colleagues at Startups
The people Anthony DiTonno works with at each company, as listed on that company's latest Form D.
Dignify Therapeutics, LLC · Form D, Sep 25, 2026
HP
Howard Palefsky
Director
NK
Neil Kurtz
Director
Karl Thor
Chief Scientific Officer and director
EG
Eric Green
Director
Edward Burgard
President and director